These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10097166)

  • 21. Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine.
    Sautter J; Kupsch A; Earl CD; Oertel WH
    Exp Brain Res; 1997 Oct; 117(1):111-9. PubMed ID: 9386009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
    Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
    Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.
    Yuan WJ; Yasuhara T; Shingo T; Muraoka K; Agari T; Kameda M; Uozumi T; Tajiri N; Morimoto T; Jing M; Baba T; Wang F; Leung H; Matsui T; Miyoshi Y; Date I
    BMC Neurosci; 2008 Aug; 9():75. PubMed ID: 18671880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat.
    Dass B; Iravani MM; Huang C; Barsoum J; Engber TM; Galdes A; Jenner P
    J Neural Transm (Vienna); 2005 Jun; 112(6):763-78. PubMed ID: 15586304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion.
    Zuch CL; Nordstroem VK; Briedrick LA; Hoernig GR; Granholm AC; Bickford PC
    J Comp Neurol; 2000 Nov; 427(3):440-54. PubMed ID: 11054705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).
    Herzog CD; Brown L; Kruegel BR; Wilson A; Tansey MG; Gage FH; Johnson EM; Bartus RT
    Neurobiol Dis; 2013 Oct; 58():38-48. PubMed ID: 23631873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
    Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
    Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system.
    Kim YS; Joo WS; Jin BK; Cho YH; Baik HH; Park CW
    Neuroreport; 1998 Jul; 9(10):2387-90. PubMed ID: 9694233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.
    Sauer H; Rosenblad C; Björklund A
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8935-9. PubMed ID: 7568047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of Bcl-2 and APP immunoreactivity after intrastriatal injection of MPP+ in the rat.
    Chuang JI; Chen ST
    Neurochem Int; 2002 Feb; 40(2):169-79. PubMed ID: 11738483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.
    Grant RJ; Clarke PB
    Neuroscience; 2002; 115(4):1281-94. PubMed ID: 12453497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration.
    Cutillas B; Espejo M; Gil J; Ferrer I; Ambrosio S
    Neuroreport; 1999 Aug; 10(12):2605-8. PubMed ID: 10574377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
    Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.
    Nouraei N; Zarger L; Weilnau JN; Han J; Mason DM; Leak RK
    Toxicol Appl Pharmacol; 2016 Apr; 296():19-30. PubMed ID: 26879220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease.
    Winter C; Hosmann K; Harnack D; Meissner W; Paul G; Morgenstern R; Kupsch A
    Synapse; 2006 Jul; 60(1):69-80. PubMed ID: 16598703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.